A11908 | Pages: NA | Jul 2022 | 477 Views | ||
Author(s) : Onkar Sumant | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Carcinoembryonic Antigen Market
Request Now !Carcinoembryonic Antigen Market Outlook - 2030
Carcinoembryonic antigen (CEA) is a substance found on the surface of some cells. It is a type of glycoprotein produced by cells of the gastrointestinal tract during embryonic development. It is produced in very small amounts after birth. The level of CEA in the bloodstream is relatively low unless certain diseases - including certain forms of cancer - are present so CEA level test is done in bloodstream to check cancer of the colon and rectum and also other cancers such as that of the pancreas, stomach, breast, lung, and medullary carcinoma of the thyroid and ovarian cancer. CEA is as a tumour marker, especially for cancers of the gastrointestinal tract. CEA is most frequently tested in blood. It can also be tested in body fluids and in biopsy tissue. Before a tumour is removed from the body CEA pre and post-surgery test is done.
Market Scope and Structural analysis:
Report Metric | Details |
 Market size available for years |  2020-2030 |
 Base year considered |  2020 |
 Forecast period |  2021–2030 |
 Forecast units |  Value (USD) |
 Segments covered |  Detected Cancer Type, Test Type, End Users and Region. |
 Geographies covered | •North America (U.S., Canada, Mexico) •Europe (France, Germany, UK, Italy, Spain, Rest of Europe) •Asia-Pacific (Japan, China, India, Australia, South Korea, Rest         of Asia-Pacific) •LAMEA (Brazil, South Arabia, South Africa, Rest of LAMEA) |
 Companies covered | Abbot, F. Hoffmann-La Roche Ltd, Quest Diagnostics, GenWay Biotech Inc., Correlogic Systems, Inc., Creative Diagnostics, Omega Diagnostics Group PLC, RayBiotech, Inc., Boster Biological Technology |
Covid-19 Analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the carcinoembryonic antigen market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:
Trends and Application:
Carcinoembryonic antigens are glycoproteins that play a major role in cell adhesion. Carcinoembryonic antigen is present at very low concentration in healthy adults. Normal carcinoembryonic antigen level in healthy adult is in range between 2.5-5.0 µg/L. Level up may increase due to benign disease or smoking. However, its concentration in serum rise very high in some types of cancer. Hence, carcinoembryonic antigen used as a marker and assist in monitoring the treatment of various malignant and non-malignant conditions. As, sensitivity and specificity are low the test is more useful for monitoring than diagnosis. Carcinoembryonic antigen detection test often carried out after the surgery to identify percent of carcinoembryonic antigen level. In humans, carcinoembryonic antigen family consist of overall 29 genes, in which 18 are normally expressed.    Â
Global carcinoembryonic antigen market segmented based on application of carcinoembryonic antigen: malignant condition and non-malignant condition. Malignant condition further subdivided into colorectal carcinoma, gastric carcinoma, pancreatic carcinoma, lung carcinoma, breast carcinoma, ovarian cancer, thyroid cancer and others. Furthermore, non-malignant condition subdivided into chronic kidney disease, pancreatitis, inflammatory bowel disease, irritable bowel syndrome, and others.
Drivers:
Increase number of cancer patients:
Cancer is considered to be the second major cause of death globally, about 70% of deaths occur from cancer in rural areas. Every year there is an increase in cancer diagnosed leading to minimally diagnostic procedures and increasing per capita healthcare expenditure, hence driving the market growth upwards. Tobacco use and alcohol use is the most prominent risk factor for cancer and is accountable for approximately 22% of cancer deaths. Resulting in need for CEA test in the market
Increase in geriatric population:
The geriatric population is more prone to chronic disease conditions, technology advancement and, government initiatives relating to cancer awareness by a non-profit organization such as Cancer Prevention and Control Research Network (CPCRN) are driving the growth of the market. CEA appears to be the most cost-effective test for the detection of potentially curable recurrent disease.
Restrains:
Key Market developments:
Some of the major players operating in global carcinoembryonic antigen market include Abbott Diagnostics, Correlogic Systems, Inc., GenWay Biotech Inc., Quest Diagnostics, and Roche Diagnostics. The market is highly consolidated, and hence companies are engaged in mergers and acquisitions. Manufacturer face continuous pressure to introduce new technology with more sensitivity in the market.
Key segments covered:
Segments | Sub-segments |
 Detected Cancer Type: |
|
 Test Type: |
|
 End Users: |
|
Key benefits of the report:
Questions answered in the Carcinoembryonic Antigen Market research report:
Key Market Segments
Segments | Sub-segments |
---|---|
By Detected Cancer Type |
|
By Test Type |
|
By End Users |
|
By Region |
|
Key Market Players
Loading Table Of Content...
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers